Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


GOP ACA-Replacement Draft: Device Tax Would Go Away; States Left To Decide Plan Coverage

Executive Summary

Under a GOP Affordable Care Act "repeal and replacement" discussion draft, all ACA taxes – including the medical device tax – would be repealed, and each state would decide what minimum essential health benefits add up to acceptable health-care coverage.

You may also be interested in...

Health Reform Roundtable Members Hold Conflicting Views On Device Tax Repeal For ACA Reform

A group of high-level health policy analysts – including former Medicare and Medicaid officials and experts at policy groups including Families USA and the American Enterprise Institute – have crafted a bipartisan recommendation for Affordable Care Act reform, but are divided on if the 2.3% device excise tax created by ACA should be repealed.

Four Republican Senators Say They Oppose Obamacare Replacement Plan

In a March 6 letter to Sen. Majority Leader Mitch McConnell, R-Kent., four GOP senators said they oppose a Feb. 10 Obamacare "Repeal and Replace" plan that has been circulating around Congress because it does not provide stability or certainty for individuals in Medicaid expansion programs. A device tax repeal is included in the plan.

Trump Criticizes FDA For 'Slow' Approvals In Speech To Congress

In his first address to a joint session of Congress, Trump spoke of a need to "slash the restraints" at US FDA and other regulatory agencies, and he reminded legislators about his executive order to eliminate two regulations for each new one written. The president's anti-regulatory posture comes as the White House is expected to seek budget cuts for domestic agencies.

Related Content


Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts